|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: ACOG Preventive med guidelines and Hep BFrom: Cheri Van Hoover (cherivh@home.com)Thu Oct 26 18:44:29 2000
Efrain Ramirez wrote:
> You are right about cross reaction but read about "Pockit" - type It doesn't look like the CDC is supporting this type of testing yet. The following web page spells out their current recommendations: http://www.cdc.gov/nchstp/dstd/Reports_Publications/Part1.htm Besides which, my other concern about serological testing is that knowing if they have antibodies for Type I or Type II HSV doesn't tell us anything about where they get their lesions. The last couple of women I cultured for genital lesions came back positive for Type I. One of these women knew exactly how she contracted it - a Hawaiian vacation where too much sun exposure caused her boyfriend's oral HSV to become active. She didn't know you could get that kind of herpes "down there." So I guess I just don't see the utility of such testing at this time. Even knowing for certain the type of HSV doesn't tell you the site of infection.
-- Cheri Van Hoover, CNM San Francisco, CA
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 04:46:07 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.